Osimertinib for Advanced EGFR-positive NSCLC Patients

Clinical trial NCT05037331 · RECRUITING

Trial details

NCT number: NCT05037331
Sponsor: National University Hospital, Singapore
Status: RECRUITING
Study type: OBSERVATIONAL

EGFR Positive Non-small Cell Lung Cancer Non Small Cell Lung Cancer

Start date: 2021-07-22
Primary completion: 2026-06-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.